| Metric | Q3 2020 | Q2 2020 | Q3 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $640M | — | — | — | — |
| Op. Income | $200M | — | — | — | — |
| Gross Margin | 73.5% | — | — | — | — |
| Net Margin | 22.1% | — | — | — | — |
| EPS (Diluted) | $0.47 | — | — | — | — |
| Free Cash Flow | $236M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $640M |
| Cost of Revenue | $170M |
| GROSS PROFIT | $470M |
| R&D Expenses | $39M |
| Selling & Marketing | $130M |
| General & Administrative | $89M |
| SG&A Expenses | $219M |
| Other Expenses | $12M |
| Operating Expenses | $270M |
| Cost & Expenses | $440M |
| OPERATING INCOME | $200M |
| Interest Income | $0 |
| Interest Expense | $32M |
| Other Income/Expenses | -$34M |
| INCOME BEFORE TAX | $166M |
| Income Tax Expense | $26M |
| Net Income from Continuing Ops | $140M |
| Net Income from Discontinued Ops | $508.0K |
| Other Adjustments | $0 |
| NET INCOME | $141M |
| Net Income Deductions | -$4M |
| BOTTOM LINE NET INCOME | $145M |
| D&A | $12M |
| EBIT | $198M |
| EBITDA | $210M |
| EPS | $1 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $640M |
| Cost of Revenue | $170M |
| GROSS PROFIT | $470M |
| R&D Expenses | $39M |
| Selling & Marketing | $130M |
| General & Administrative | $89M |
| SG&A Expenses | $219M |
| Other Expenses | $12M |
| Operating Expenses | $270M |
| Cost & Expenses | $440M |
| OPERATING INCOME | $200M |
| Interest Income | $0 |
| Interest Expense | $32M |
| Other Income/Expenses | -$34M |
| INCOME BEFORE TAX | $166M |
| Income Tax Expense | $26M |
| Net Income from Continuing Ops | $140M |
| Net Income from Discontinued Ops | $508.0K |
| Other Adjustments | $0 |
| NET INCOME | $141M |
| Net Income Deductions | -$4M |
| BOTTOM LINE NET INCOME | $145M |
| D&A | $12M |
| EBIT | $198M |
| EBITDA | $210M |
| EPS | $1 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $141M |
| Depreciation & Amortization | $12M |
| Stock-Based Compensation | $37M |
| Deferred Income Tax | $17M |
| Other Non-Cash Items | $11M |
| Change in Working Capital | $32M |
| OPERATING CASH FLOW | $250M |
| Capital Expenditure | -$14M |
| Acquisitions (Net) | -$1.4B |
| Purchases of Investments | -$9M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$963M |
| NET CASH FROM INVESTING | -$2.4B |
| Net Debt Issuance | -$34M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$113M |
| NET CASH FROM FINANCING | $1.4B |
| FREE CASH FLOW | $236M |
| Net Change in Cash | $270M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $399M |
| Short-Term Investments | $0 |
| Net Receivables | $200M |
| Inventory | $0 |
| Other Current Assets | $140M |
| TOTAL CURRENT ASSETS | $738M |
| PP&E (Net) | $106M |
| Goodwill | $1.3B |
| Intangible Assets | $226M |
| Long-Term Investments | $0 |
| Tax Assets | $237M |
| Other Non-Current Assets | $111M |
| TOTAL NON-CURRENT ASSETS | $1.9B |
| TOTAL ASSETS | $2.7B |
| Account Payables | $16M |
| Short-Term Debt | $0 |
| Deferred Revenue | $241M |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $488M |
| Long-Term Debt | $3.5B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $18M |
| Other Non-Current Liabilities | $83M |
| TOTAL NON-CURRENT LIABILITIES | $3.6B |
| TOTAL LIABILITIES | $4.1B |
| Common Stock | $264.0K |
| Additional Paid-In Capital | $7.3B |
| Retained Earnings | -$8.6B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$108M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | -$1.4B |
| Minority Interest | $3M |
| TOTAL EQUITY | -$1.4B |
| TOTAL LIABILITIES & EQUITY | $2.7B |
| Total Debt | $3.5B |
| Net Debt | $3.1B |
